Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SELP | P16109 | 10/20 | 0.46 |
| ▸ | SELL | P14151 | 9/20 | 0.46 |
| ▸ | TLR4 | O00206 | 1/20 | 0.41 |
| ▸ | AKT1 | P31749 | 1/20 | 0.39 |
| ▸ | CD44 | P16070 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15370423 | 1.00 | SELP (0.46) | SELPSELLTLR4AKT1CD44 | |
| SCHEMBL29944201 | 1.00 | SELP (0.46) | SELPSELLTLR4AKT1CD44 | |
| SCHEMBL31117388 | 1.00 | SELP (0.46) | SELPSELLTLR4AKT1CD44 | |
| SCHEMBL29721437 | 1.00 | SELP (0.46) | SELPSELLTLR4AKT1CD44 | |
| SCHEMBL28875524 | 1.00 | SELP (0.46) | SELPSELLTLR4AKT1CD44 | |
| SCHEMBL30424916 | 1.00 | SELP (0.46) | SELPSELLTLR4AKT1CD44 | |
| SCHEMBL374171 | 1.00 | SELP (0.46) | SELPSELLTLR4AKT1CD44 | |
| SCHEMBL17907881 | 1.00 | SELP (0.46) | SELPSELLTLR4AKT1CD44 | |
| SCHEMBL22343497 | 1.00 | SELP (0.46) | SELPSELLTLR4AKT1CD44 | |
| SCHEMBL26742858 | 1.00 | SELP (0.46) | SELPSELLTLR4AKT1CD44 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024132679-A1 | COMPOSITIONS CONTAINING BIOSURFACTANTS AND DESFERRIOXAMINES | EVONIK DR. STRAETMANS GMBH (DE) | 2024-06-27 | — | — | WO | disclosed |
| US-11999901-B2 | Multifunctional wax dispersant for subterranean chemical applications | EVONIK OPERATIONS GMBH (DE) | 2024-06-04 | — | — | US | disclosed |
| EP-3221326-B1 | CONCENTRATED LOW-VISCOSITY RHAMNOLIPID COMPOSITIONS | EVONIK OPERATIONS GMBH (DE) | 2024-05-01 | — | — | EP | disclosed |
| EP-4361238-A1 | COMPOSITIONS COMPRISING GLYCAMINES | ChemTEK UG (haftungsbeschränkt) (DE) | 2024-05-01 | — | — | EP | disclosed |
| US-11918670-B2 | Mixture composition comprising glycolipids and triethyl citrate | EVONIK OPERATIONS GMBH (DE) | 2024-03-05 | — | — | US | disclosed |
| US-20230416596-A1 | MULTIFUNCTIONAL WAX DISPERSANT FOR SUBTERRANEAN CHEMICAL APPLICATIONS | EVONIK OPERATIONS GMBH (DE) | 2023-12-28 | — | — | US | disclosed |
| US-20230348777-A1 | MULTIFUNCTIONAL WAX DISPERSANT FOR SUBTERRANEAN CHEMICAL APPLICATIONS | EVONIK OPERATIONS GMBH (DE) | 2023-11-02 | — | — | US | disclosed |
| EP-3934613-B1 | RHAMNOLIPIDS AS DEPOSITION AID | EVONIK OPERATIONS GMBH (DE) | 2023-11-01 | — | — | EP | disclosed |
| EP-4269530-A1 | MULTIFUNCTIONAL WAX DISPERSANT FOR SUBTERRANEAN CHEMICAL APPLICATIONS | Evonik Operations GmbH (DE) | 2023-11-01 | — | — | EP | disclosed |
| EP-4269531-A1 | MULTIFUNCTIONAL WAX DISPERSANT FOR SUBTERRANEAN CHEMICAL APPLICATIONS | Evonik Operations GmbH (DE) | 2023-11-01 | — | — | EP | disclosed |
| US-20230121094-A1 | MIXTURE COMPOSITION COMPRISING GLYCOLIPIDS AND TRIETHYL CITRATE | EVONIK OPERATIONS GMBH (DE) | 2023-04-20 | — | — | US | disclosed |
| EP-4155371-A1 | COMPOSITION RICH IN MONO-RHAMNOLIPIDS | Evonik Operations GmbH (DE) | 2023-03-29 | — | — | EP | disclosed |
| US-11606963-B2 | Composition containing glycolipids and preservatives | EVONIK OPERATIONS GMBH (DE) | 2023-03-21 | — | — | US | disclosed |
| US-20220183958-A1 | Rhamnolipids as deposition aid | EVONIK OPERATIONS GMBH (DE) | 2022-06-16 | — | — | US | disclosed |
| US-20210337835-A1 | COMPOSITION CONTAINING GLYCOLIPIDS AND PRESERVATIVES | EVONIK OPERATIONS GMBH (DE) | 2021-11-04 | — | — | US | disclosed |
| US-10604722-B2 | Concentrated, low-viscosity rhamnolipid compositions | EVONIK OPERATIONS GMBH (DE) | 2020-03-31 | — | — | US | disclosed |
| US-20190269158-A1 | COMPOSITION CONTAINING GLYCOLIPIDS AND PRESERVATIVES | EVONIK DEGUSSA GMBH (DE) | 2019-09-05 | — | — | US | disclosed |
| US-20170335238-A1 | CONCENTRATED, LOW-VISCOSITY RHAMNOLIPID COMPOSITIONS | EVONIK OPERATIONS GMBH (DE) | 2017-11-23 | — | — | US | disclosed |
| EP-3023431-B1 | Concentrated, low viscosity rhamnolipid compounds | EVONIK DEGUSSA GMBH (DE) | 2017-01-04 | — | — | EP | disclosed |
| EP-3023431-A1 | Concentrated, low viscosity rhamnolipid compounds | Evonik Degussa GmbH (DE) | 2016-05-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230121094-A1 | MIXTURE COMPOSITION COMPRISING GLYCOLIPIDS AND TRIETHYL CITRATE | PHOSPHO1, TEC, SGMS2 | SELP 2506/4885SELL 2922/4885TLR4 4618/4885 |
| US-20210337835-A1 | COMPOSITION CONTAINING GLYCOLIPIDS AND PRESERVATIVES | UGCG, LIPC, FABP4 | SELP 461/4885SELL 391/4885TLR4 1294/4885 |
| US-20170335238-A1 | CONCENTRATED, LOW-VISCOSITY RHAMNOLIPID COMPOSITIONS | RHOC, SGMS1, SGMS2 | SELP 732/4885SELL 783/4885TLR4 2317/4885 |
| US-11606963-B2 | Composition containing glycolipids and preservatives | UGCG, LIPC, FABP4 | SELP 461/4885SELL 391/4885TLR4 1294/4885 |
| US-20220183958-A1 | Rhamnolipids as deposition aid | LRAT, DDOST, PHOSPHO1 | SELP 269/4885SELL 902/4885TLR4 2742/4885 |
| US-10604722-B2 | Concentrated, low-viscosity rhamnolipid compositions | RHOC, SGMS1, SGMS2 | SELP 734/4885SELL 778/4885TLR4 2278/4885 |
| US-11918670-B2 | Mixture composition comprising glycolipids and triethyl citrate | TEC, PHOSPHO1, UGCG | SELP 2805/4885SELL 3107/4885TLR4 4775/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.